Millennium Management’s Oncternal Therapeutics ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-61,205
Closed -$80.8K – 6684
2024
Q3
$80.8K Sell
61,205
-41,731
-41% -$202K ﹤0.01% 5617
2024
Q2
$782K Sell
102,936
-159
-0.2% -$1.37K ﹤0.01% 4282
2024
Q1
$928K Buy
103,095
+300
+0.3% +$2.64K ﹤0.01% 4357
2023
Q4
$1.1M Buy
102,795
+20,433
+25% +$147K ﹤0.01% 4074
2023
Q3
$500K Buy
82,362
+118
+0.1% +$831 ﹤0.01% 4662
2023
Q2
$567K Buy
82,244
+7,467
+10% +$49.2K ﹤0.01% 4449
2023
Q1
$1.17M Buy
74,777
+16,790
+29% +$330K ﹤0.01% 3941
2022
Q4
$1.16M Buy
57,987
+28,742
+98% +$572K ﹤0.01% 4017
2022
Q3
$522K Sell
29,245
-35,561
-55% -$763K ﹤0.01% 4941
2022
Q2
$1.44M Buy
64,806
+42,300
+188% +$943K ﹤0.01% 4033
2022
Q1
$626K Buy
22,506
+2,093
+10% +$76.2K ﹤0.01% 4936
2021
Q4
$927K Buy
20,413
+4,480
+28% +$301K ﹤0.01% 4480
2021
Q3
$1.33M Buy
15,933
+8,225
+107% +$680K ﹤0.01% 4371
2021
Q2
$732K Sell
7,708
-12,057
-61% -$1.43M ﹤0.01% 4957
2021
Q1
$3.29M Buy
19,765
+3,908
+25% +$517K ﹤0.01% 3036
2020
Q4
$1.55M Buy
15,857
+14,086
+795% +$891K ﹤0.01% 3429
2020
Q3
$60K Sell
1,771
-1,357
-43% -$66.5K ﹤0.01% 4284
2020
Q2
$178K Sell
3,128
-136
-4% -$7.67K ﹤0.01% 3875
2020
Q1
$191K Sell
3,264
-144
-4% -$10.7K ﹤0.01% 3409
2019
Q4
$269K Sell
3,408
-1,503
-31% -$156K ﹤0.01% 3719
2019
Q3
$491K Buy
+4,911
New +$503K ﹤0.01% 3272
2019
Q1
– Sell
-106
Closed -$12K – 4421
2018
Q4
$12K Sell
106
-1,365
-93% -$273K ﹤0.01% 3682
2018
Q3
$323K Buy
1,471
+1,323
+894% +$3.17M ﹤0.01% 3452
2018
Q2
$318K Sell
148
-723
-83% -$1.83M ﹤0.01% 3365
2018
Q1
$2.16M Buy
871
+450
+107% +$1M ﹤0.01% 2262
2017
Q4
$749K Buy
+421
New +$610K ﹤0.01% 2881
2017
Q2
– Sell
-445
Closed -$305K – 3974
2017
Q1
$305K Sell
445
-194
-30% -$142K ﹤0.01% 3036
2016
Q4
$472K Buy
639
+623
+3,894% +$666K ﹤0.01% 2698
2016
Q3
$17K Buy
+16
New +$14K ﹤0.01% 3219
2015
Q1
– Sell
-36
Closed -$37K – 4229
2014
Q4
$37K Buy
36
+8
+29% +$7.14K ﹤0.01% 3839
2014
Q3
$29K Buy
28
+7
+33% +$10.3K ﹤0.01% 3626
2014
Q2
$40K Buy
+21
New +$41.6K ﹤0.01% 3309
2013
Q3
– Sell
-39
Closed -$360K – 3644
2013
Q2
$360K Buy
+39
New +$301K ﹤0.01% 2494

Other funds holding ONCT

Millennium Management's ONCT Position: Q4 2024 in Review

Millennium Management sold out of Oncternal Therapeutics (ONCT) in Q4 2024, closing a stake of 61,205 shares — an estimated $80.8K sold.

Millennium Management first reported a position in ONCT in Q2 2013 and held it in 33 quarters. The position peaked at $3.29M in Q1 2021. 4 funds tracked by Wall St. Rank hold ONCT as of Q4 2024.

  • Millennium Management reported no remaining Oncternal Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Millennium Management sold 61,205 Oncternal Therapeutics shares in Q4 2024, an estimated $80.8K.
  • Millennium Management first reported a position in Oncternal Therapeutics in Q2 2013 and held it in 33 quarters.
  • Millennium Management's Oncternal Therapeutics position peaked at $3.29M in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Oncternal Therapeutics as of Q4 2024.

Based on Millennium Management's 13F filing for Q4 2024, filed 14 Feb 2025.